Virax Biolabs Group Ltd. Class A's total assets for Q4 2025 were $6.43M, a decrease of -31.94% from the previous quarter. VRAX total liabilities were $964.75K for the fiscal quarter, a -5.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.